Victor W. Armstrong - Concepedia

Author

Victor W. Armstrong

Also Known As

Armstrong V W, V ARMSTRONG, V Armstrong, V W Armstrong, V W. Armstrong, V. Armstrong, V. W. ARMSTRONG, V. W. Armstrong, V. W. Armstrong,, V.-W. Armstrong

291

Publications

12.3K

Citations

H-Index

198

Concepts

All Affiliations

University of Göttingen Heidelberg University Universitätsmedizin Göttingen University Hospital Heidelberg

About

Victor W. Armstrong is an author at University of Göttingen specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	75	5K
2	Natural Sciences	13	14	685
3	Health Sciences	10	10	246
4	Engineering	4	4	128
5	Public Health	2	2	663

Victor W. Armstrong

160

Publications

10.4K

Citations

H-Index

Page 1

	Year	Citations
The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosisDependence on serum LDL levels Victor W. Armstrong, Peter Cremer, E. Eberle, Atherosclerosis Vascular DiseaseSerum Ldl LevelsCardiovascular DiseaseHyperlipidemiaVascular Biology	1986	630
Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference Pierre Wallemacq, Victor W. Armstrong, Merçè Brunet, Therapeutic Drug Monitoring Uniform DoseSolid Organ TransplantationTransplantation MedicineSurgeryPharmacotherapy	2009	453
The Pharmacokinetic-Pharmacodynamic Relationship for Total and Free Mycophenolic Acid in Pediatric Renal Transplant Recipients Lutz T. Weber, Maria Shipkova, Victor W. Armstrong, Journal of the American Society of Nephrology TransplantationKidney TransplantMycophenolic AcidMedicinePharmacokinetic-pharmacodynamic Relationship	2002	278
No Influence of the MDR-1 C3435T Polymorphism or a CYP3A4 Promoter Polymorphism (CYP3A4-V Allele) on Dose-adjusted Cyclosporin A Trough Concentrations or Rejection Incidence in Stable Renal Transplant Recipients Nicolas von Ahsen, Michael Richter, Clemens Grupp, Clinical Chemistry	2001	261
Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a) Victor W. Armstrong, Autar K. Walli, D. Seidel Journal of Lipid Research	1985	225
Contribution of CYP3A5 to the in Vitro Hepatic Clearance of Tacrolimus Landry K. Kamdem, Frank Streit, Ulrich M. Zanger, Clinical Chemistry	2005	219
Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. Lutz T. Weber, Maria Shipkova, T. Lamersdorf, Journal of the American Society of Nephrology Transplantation MedicinePharmacotherapyPharmacokineticsMycophenolate MofetilRenal Function	1998	218
Identification of glucoside and carboxyl‐linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil Maria Shipkova, Victor W. Armstrong, Eberhard Wieland, British Journal of Pharmacology	1999	211
Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea Bart Maes, Ignace Dalle, Karen Geboes, Transplantation	2003	194
Rapid Liquid Chromatography–Tandem Mass Spectrometry Routine Method for Simultaneous Determination of Sirolimus, Everolimus, Tacrolimus, and Cyclosporin A in Whole Blood Frank Streit, Victor W. Armstrong, Michael Oellerich Clinical Chemistry ImmunologyCyclosporin AWhole BloodPharmacotherapyImmunotherapy	2002	190

Page 1